Mutations can reduce effect of hormonal treatment in early breast cancer

Artificial intelligence could create better outcomes for bowel cancer patients

New research data on the regulation of hormone-dependent breast cancer

A new study identifies interleukin 11 as a marker of cancer-associated fibroblasts